The HHS will require all new vaccines to undergo placebo-controlled trials, likely slowing down approvals and decreasing access.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

Prefrontal-cerebellar transcranial pulsed current stimulation significantly improved social functioning and sleep scores over 4 weeks.

The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.

Phototherapy with topical antioxidants is the most effective combination for vitiligo, followed by corticosteroids and calcineurin inhibitors.

Three children have died in the most recent outbreak of measles. This article reviews the symptoms and treatment of measles.

Investment in permanent nurse staffing would decrease hospital costs and improve patient outcomes including mortality.

Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.

Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

The drug, called medetomidine, is used by veterinarians to sedate pets. It’s similar to xylazine, another animal drug that has already made the U.S. opioid crisis worse, The Associated Press reported.

Pregnant patients with T2IDs using dupilumab did not have an increased rate of adverse events when compared with patients not receiving dupilumab.